Skip to content
Screener

Bio-Techne TECH Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Danaher logo
DanaherDHR
$1.3B+8.3%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$12.02M+24.3%
Agilent Technologies logo
Agilent TechnologiesA
$187M-1.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$36.2M-12.3%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$22.79M-20.4%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$12.19M+30.0%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.26B+43.3%
Enterprise value$11.34B+39.3%
P/E75.2×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemMarch 31, 2026 / (unaudited)June 30, 2025
Accrued expenses17,68225,663
Contract liabilities38,43332,571
Income taxes payable2,97110,770
Operating lease liabilities - current14,18114,098
Other current liabilities2,0921,645
Total current liabilities153,278175,849
Deferred income taxes14,2106,169
Long-term debt obligations200,000346,000

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's operating lease liabilities (current)?
Bio-Techne (TECH) reported operating lease liabilities (current) of $14.18M in Q1 2026.
How has Bio-Techne's operating lease liabilities (current) changed year-over-year?
Bio-Techne's operating lease liabilities (current) increased by 0.9% year-over-year, from $14.05M to $14.18M.
What is the long-term trend for Bio-Techne's operating lease liabilities (current)?
Over 4 years (2021 to 2025), Bio-Techne's operating lease liabilities (current) has grown at a 5.0% compound annual growth rate (CAGR), from $11.6M to $14.1M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Bio-Techne's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude